Monash University researchers have gained insights into how nanoparticles could develop a biosensor to prevent deadly diseases contracted on medical equipment, such as catheters.
- Monash University researchers have gained insights into how nanoparticles could develop a biosensor to prevent deadly diseases contracted on medical equipment, such as catheters.
- Candida albicans can become a serious problem for people who are seriously ill or immune-suppressed.
Researchers at Monash University have gained insights into how nanoparticles could be used to identify the presence of invasive and sometimes deadly microbes, and deliver targeted treatments more effectively.
This study was conducted as an interdisciplinary collaboration between microbiologists, immunologists and engineers led by Dr Simon Corrie from Monash University’s Department of Chemical Engineering and Professor Ana Traven from the Monash Biomedicine Discovery Institute (BDI). It was recently published in the American Chemical Society journal ACS Applied Interfaces and Material.
Candida albicans, a commonly found microbe, can turn deadly when it colonises on devices such as catheters implanted in the human body. While commonly found in healthy people, this microbe can become a serious problem for those who are seriously ill or immune-suppressed.
The microbeforms a biofilm when it colonises using, for example, a catheter as a source of infection. It then spreads into the bloodstream to infect internal organs.
“The mortality rate in some patient populations can be as high as 30 to 40 per cent even if you treat people. When it colonises, it’s highly resistant to anti-fungal treatments,” Professor Traven said.
“The idea is that if you can diagnose this infection early, then you can have a much bigger chance of treating it successfully with current anti-fungal drugs and stopping a full-blown systemic infection, but our current diagnostic methods are lacking. A biosensor to detect early stages of colonisation would be highly beneficial.”
The researchers investigated the effects of organosilica nanoparticles of different sizes, concentrations and surface coatings to see whether and how they interacted with both C. albicans and with immune cells in the blood.
They found that the nanoparticles bound to fungal cells, but were non-toxic to them.
“They don’t kill the microbe, but we can make an anti-fungal particle by binding them to a known anti-fungal drug,” Professor Traven said.
The researchers also demonstrated that the particles associate with neutrophils – human white blood cells – in a similar way as they did with C. albicans, remaining noncytotoxic towards them.
“We’ve identified that these nanoparticles, and by inference a number of different types of nanoparticles, can be made to be interactive with cells of interest,” Dr Corrie said.
“We can actually change the surface properties by attaching different things; thereby we can really change the interactions they have with these cells – that’s quite significant.”
Dr Corrie said while nanoparticles were being investigated in the treatment of cancer, the use of nanoparticle-based technologies in infectious diseases lags behind the cancer nanomedicine field, despite the great potential for new treatments and diagnostics.
“The other unique thing in this study is that rather than using cells grown in culture, we’re also looking at how particles act in whole human blood and with neutrophils extracted from fresh human blood,” he said.
Professor Traven said the study had benefited greatly from interdisciplinary collaboration.
“We’ve brought together labs with expertise in infection, microbiology and immunology with a lab that has expertise in engineering, to do state-of-the-art experiments,” she said.
The Latest on: Nanoparticle biosensor
via Google News
The Latest on: Nanoparticle biosensor
- Using Nanotechnology to Identify those Most at Risk from COVID-19on June 19, 2020 at 2:48 am
The test utilizes a particular molecule coupled to the gold nanoparticles to detect a specific protein that is part of the genetic sequence unique to COVID-19. When the biosensor (gold nanoparticles) ...
- Sirakoss scores FDA nod for nanoparticle synthetic bone graft substituteon June 18, 2020 at 3:23 pm
LONDON – Sirakoss Ltd. has received FDA 510(k) clearance for its nanoparticle synthetic bone graft substitute, after showing the ready-to-use putty is equivalent to the CE-approved dry formulation.
- Emissions and exposures of graphene nanomaterials, titanium dioxide nanofibers, and nanoparticles during down-stream industrial handlingon June 15, 2020 at 5:00 pm
 showed that many exposure assessments have been done for carbon nanotubes (CNTs), carbon nanofibers (CNFs), and titanium dioxide nanoparticles ... transistors , biosensors , cancer ...
- Materials Research Gets Under the Skinon June 11, 2020 at 5:00 pm
Scientists push biocompatible materials to interact with their surroundings in intelligent ways ...
- Nanocrystal assembly method could transform photonics deviceson June 11, 2020 at 8:23 am
A new method of nanocrystal assembly developed by Australian scientists could transform a range of photonics-based consumer devices and technologies, including smart phones, tablets and laptop ...
- Covid Snippetson June 2, 2020 at 5:00 pm
If the viral protein is present in the sample, the molecule (acting as a biosensor) binds to it and the attached gold nanoparticle changes the colour of the liquid reagent from purple to blue ...
- Researchers develop experimental rapid COVID-19 test using nanoparticle techniqueon May 29, 2020 at 9:10 am
When the biosensor binds to the virus's gene sequence, the gold nanoparticles respond by turning the liquid reagent from purple to blue. "The accuracy of any COVID-19 test is based on being able ...
- Researchers develop experimental rapid COVID-19 test using nanoparticle techniqueon May 29, 2020 at 7:53 am
The test uses a highly specific molecule attached to the gold nanoparticles to detect a particular protein. This protein is part of the genetic sequence that is unique to the novel coronavirus. When ...
- Microbial cyborgs: Bacteria supplying poweron May 25, 2020 at 3:35 am
One day, however, “microbial cyborgs” might be used in fuel cells, biosensors, or bioreactors ... are embedded in a composite made of carbon nanotubes (gray) and silica nanoparticles (violet) ...
via Bing News